Alphamab Oncology (HKG:9966)

Alphamab Oncology Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 17, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,986	3,368	6,407	10,149	12,743	15,221
Market Cap Growth	-47.42%	-47.42%	-36.88%	-20.36%	-16.28%	21.20%
Enterprise Value	6,512	2,154	5,004	8,763	10,814	12,776
Last Close Price	8.30	3.50	6.64	10.80	13.60	16.28
PE Ratio	45.88	19.03	-	-	-	-
PS Ratio	11.72	4.95	26.58	53.81	71.10	-
PB Ratio	4.10	1.73	3.48	5.76	5.55	5.64
P/TBV Ratio	4.10	1.73	3.48	5.76	5.55	5.64
P/FCF Ratio	39.38	16.61	-	-	-	-
P/OCF Ratio	35.34	14.91	-	-	-	-
EV/Sales Ratio	9.56	3.16	20.76	46.46	60.34	-
EV/EBITDA Ratio	34.37	12.24	-	-	-	-
EV/EBIT Ratio	60.58	20.04	-	-	-	-
EV/FCF Ratio	32.11	10.62	-	-	-	-
Debt / Equity Ratio	0.10	0.10	0.15	0.22	0.34	0.10
Debt / EBITDA Ratio	1.04	1.04	-	-	-	-
Debt / FCF Ratio	0.98	0.98	-	-	-	-
Asset Turnover	0.29	0.29	0.10	0.07	0.06	-
Inventory Turnover	0.75	0.75	0.77	0.72	0.06	-
Quick Ratio	6.41	6.41	5.55	3.72	3.22	6.52
Current Ratio	6.74	6.74	5.84	3.88	3.32	6.67
Return on Equity (ROE)	9.49%	9.49%	-13.04%	-19.00%	-19.91%	-18.21%
Return on Assets (ROA)	2.88%	2.88%	-9.50%	-11.21%	-9.72%	-9.32%
Return on Capital (ROIC)	3.20%	3.20%	-10.55%	-12.25%	-10.38%	-9.89%
Return on Capital Employed (ROCE)	5.10%	5.10%	-	-	-	-
Earnings Yield	2.22%	5.25%	-3.62%	-3.63%	-3.97%	-3.34%
FCF Yield	2.54%	6.02%	-4.11%	-4.79%	-4.61%	-3.42%
Buyback Yield / Dilution	-2.53%	-2.53%	-2.50%	-0.11%	-0.62%	-73.29%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.